» Articles » PMID: 29142105

The Genomic Locus Can Affect Treatment of Psychiatric Illness Through Gene Expression Changes Related to MicroRNA-484

Abstract

Genetic studies of familial schizophrenia in Finland have observed significant associations with a group of biologically related genes, , , , and , the 'DISC1 network'. Here, we use gene expression and psychoactive medication use data to study their biological consequences and potential treatment implications. Gene expression levels were determined in 64 individuals from 18 families, while prescription medication information has been collected over a 10-year period for 931 affected individuals. We demonstrate that the SNP rs2242549 associates with significant changes in gene expression for 2908 probes (2542 genes), of which 794 probes (719 genes) were replicable. A significant number of the genes altered were predicted targets of microRNA-484 ( = 3.0 × 10), located on a non-coding exon of Variants within the locus also displayed significant genotype by gender interaction to early cessation of psychoactive medications metabolized by CYP2C19. Furthermore, we demonstrate that miR-484 can affect the expression of CYP2C19 in a cell culture system. Thus, variation at the locus may alter risk of mental illness, in part through modification of miR-484, and such modification alters treatment response to specific psychoactive medications, leading to the potential for use of this locus in targeting treatment.

Citing Articles

Concurrent de novo MACF1 mutation and inherited 16p13.11 microduplication in a preterm newborn with hypotonia, joint hyperlaxity and multiple congenital malformations: a case report.

Mi L, Yao R, Guo W, Wang J, Zhang G, Ye X BMC Pediatr. 2024; 24(1):528.

PMID: 39152427 PMC: 11328432. DOI: 10.1186/s12887-024-04628-y.


Targets and Affects Preadipocytes Proliferation, Differentiation, and Apoptosis.

Yang M, Gao X, Hu C, Wang S, Sheng H, Ma Y Int J Mol Sci. 2023; 24(16).

PMID: 37628891 PMC: 10454478. DOI: 10.3390/ijms241612710.


Phenotypic Impact of Rare Potentially Damaging Copy Number Variation in Obsessive-Compulsive Disorder and Chronic Tic Disorders.

Mahjani B, Birnbaum R, Buxbaum Grice A, Cappi C, Jung S, Avila M Genes (Basel). 2022; 13(10).

PMID: 36292681 PMC: 9601402. DOI: 10.3390/genes13101796.


miR-484: A Potential Biomarker in Health and Disease.

Jia Y, Liu J, Wang G, Song Z Front Oncol. 2022; 12:830420.

PMID: 35356223 PMC: 8959652. DOI: 10.3389/fonc.2022.830420.


Underrepresentation of Phenotypic Variability of 16p13.11 Microduplication Syndrome Assessed With an Online Self-Phenotyping Tool (Phenotypr): Cohort Study.

Li J, Hojlo M, Chennuri S, Gujral N, Paterson H, Shefchek K J Med Internet Res. 2021; 23(3):e21023.

PMID: 33724192 PMC: 8074853. DOI: 10.2196/21023.


References
1.
Stoll G, Pietilainen O, Linder B, Suvisaari J, Brosi C, Hennah W . Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nat Neurosci. 2013; 16(9):1228-1237. PMC: 3986889. DOI: 10.1038/nn.3484. View

2.
Malhotra D, Sebat J . CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012; 148(6):1223-41. PMC: 3351385. DOI: 10.1016/j.cell.2012.02.039. View

3.
Fujitani M, Zhang S, Fujiki R, Fujihara Y, Yamashita T . A chromosome 16p13.11 microduplication causes hyperactivity through dysregulation of miR-484/protocadherin-19 signaling. Mol Psychiatry. 2016; 22(3):364-374. PMC: 5322274. DOI: 10.1038/mp.2016.106. View

4.
Kimura H, Tsuboi D, Wang C, Kushima I, Koide T, Ikeda M . Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility. Schizophr Bull. 2014; 41(3):744-53. PMC: 4393687. DOI: 10.1093/schbul/sbu147. View

5.
Bakircioglu M, P Carvalho O, Khurshid M, Cox J, Tuysuz B, Barak T . The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis. Am J Hum Genet. 2011; 88(5):523-35. PMC: 3146716. DOI: 10.1016/j.ajhg.2011.03.019. View